PDF-LeadingEdgePrimaryAdaptiveandAcquiredResistancetoCancerImmunotherapy

PDF-LeadingEdgePrimaryAdaptiveandAcquiredResistancetoCancerImmunotherapy thumbnail
February920172017ElsevierInc 10yearsormoreinasubsetofapproximately21ofpatientsSchadendorfetal2015In2015ipilimumabwasalsoapprovedbytheFDAasadjuvanttherapyforlocallyadvancedmelanomaDuetoenhanc

Download Presentation

"LeadingEdgePrimaryAdaptiveandAcquiredResistancetoCancerImmun " is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.

Presentation Transcript

Transcript not available.

Related Topics